Researchers shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut cancers.
Researchers at the University of Alabama at Birmingham's division of gastrointestinal surgery and gastroenterology and hepatology were awarded a $120,000 grant from the Alabama Department of Public ...